Search

everythinglearnresearchcommunity

for

Search:↓

People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.

AGA patients have higher insulin resistance and serum progranulin levels, suggesting a link to metabolic issues.

Low PON1 levels may indicate and predict the severity of hair loss.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Smoking and drinking can lower vitamin levels and potentially trigger early hair loss, but overall vitamin levels don't seem to affect hair loss duration.

Men with hair loss don't necessarily have higher levels of the hormone DHEA-S, but this hormone tends to decrease with age.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Men with androgenetic alopecia have unique metabolomic patterns that could help develop targeted treatments.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

The serum increased hair density and was well-tolerated, but didn't affect hair thickness or shedding.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Females with androgenic alopecia have significantly lower vitamin D3 and ferritin levels.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Women with androgenetic alopecia have lower SHBG levels.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Scalp fungi and sebum differences may affect hair loss in men.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

Clove oil nanoemulsion hair serum may effectively treat hair loss.